{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T11:24:24Z","timestamp":1791113064194,"version":"4.1.0"},"reference-count":74,"publisher":"American Society of Hematology","issue":"1","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2001,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>This paper examines the current state of the blood supply in the US and focuses on the potential for augmenting blood availability by attention to the iron status of donors. Increasing demands are being made upon the national blood supply as rates of blood donation are declining, in part because of the loss of blood donors as a result of enhanced screening and testing procedures. Iron-related means of expanding the blood supply include the use of blood from individuals undergoing therapeutic phlebotomy for hereditary hemochromatosis and enhancing the retention and commitment of women of childbearing age as donors by using iron supplementation to prevent iron deficiency.<\/jats:p><jats:p>In Section I, Dr. Klein discuss the circumstances responsible for a decline in the population of eligible donors, including public attitudes toward donation, factors influencing the retention of donors by blood centers, and the effects of increased screening and testing to maintain the safety of the blood supply.<\/jats:p><jats:p>In Section II, Drs. Kushner and Ajioka focus on the consequences of the decision by the US Food and Drug Administration (FDA) to develop recommendations to permit blood centers to collect blood from patients with hereditary hemochromatosis and to distribute this blood obtained without disease labeling if all other screening and testing procedures are passed. After summarizing the pathophysiology of hereditary hemochromatosis, the use by blood centers of blood obtained from heterozygotes and homozygotes for hereditary hemochromatosis is considered.<\/jats:p><jats:p>In Section III, Dr. Brittenham reviews the use of low dose, short-term carbonyl iron supplementation for women donors of childbearing age. Replacing the iron lost at donation can help prevent iron deficiency in women of childbearing age and, by decreasing deferral, enhance the retention and commitment of women who give blood regularly. He emphasizes the use by blood centers of iron-related means to enhance recruitment and retention of blood donors.<\/jats:p>","DOI":"10.1182\/asheducation-2001.1.422","type":"journal-article","created":{"date-parts":[[2003,8,28]],"date-time":"2003-08-28T00:29:50Z","timestamp":1062030590000},"page":"422-432","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":30,"title":["Preserving the National Blood Supply"],"prefix":"10.1182","volume":"2001","author":[{"given":"Gary M.","family":"Brittenham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harvey G.","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James P.","family":"Kushner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard S.","family":"Ajioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2020021223124193900_R1","unstructured":"Comprehensive report on blood collection and transfusion in the United States in 1999. National Blood Data Resource Center; 2001."},{"key":"2020021223124193900_R2","unstructured":"Comprehensive report on blood collection and transfusion in 1997. National Blood Data Resource Center; 1999"},{"key":"2020021223124193900_R3","unstructured":"Schafer IA, Mosley JW. A study of viral hepatitis in a penal institution. Ann Intern Med. 1958;149:1162"},{"key":"2020021223124193900_R4","doi-asserted-by":"crossref","unstructured":"Krugman S, Friedman H, Latimer C. Hepatitis A and B. Serologic survey of various population groups. Am J Med Sci. 1978;275:249","DOI":"10.1097\/00000441-197805000-00002"},{"key":"2020021223124193900_R5","unstructured":"Drake A, Finkelstein S, Sapolsky H. The American Blood Supply. MIT Press: Cambridge MA; 1982."},{"key":"2020021223124193900_R6","unstructured":"Ness PM, Lipton KS. Hemochromatosis: questions and answers. Am Assoc Blood Banks Bulletin. 00-2, 2000."},{"key":"2020021223124193900_R7","unstructured":"Edwards C. Hemochromatosis. In Lee GR, Foerster J, Lukens J, Paraskevas F, Greer JP, Rodgers GM, eds. Wintrobe's Clinical Hematology, Vol. 1. Baltimore, MD: Lippincott Williams & Wilkins; 1999:1056-1070."},{"key":"2020021223124193900_R8","doi-asserted-by":"crossref","unstructured":"Feder JN, Gnirke A, Thomas W, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nature Genetics. 1996;13:399\u2013408.","DOI":"10.1038\/ng0896-399"},{"key":"2020021223124193900_R9","doi-asserted-by":"crossref","unstructured":"Bennett MJ, Lebron JA, Bjorkman PJ. Crystal structure of the hereditary haemochromatosis protein HFE complexed with transferrin receptor.Nature. 2000;403:46\u201353.","DOI":"10.1038\/47417"},{"key":"2020021223124193900_R10","doi-asserted-by":"crossref","unstructured":"Lebron JA, Bennett MJ, Vaughn DE, et al. Crystal structure of the hemochromatosis protein HFE and characterization of its interaction with transferrin receptor.Cell. 1998;93:111\u2013123.","DOI":"10.1016\/S0092-8674(00)81151-4"},{"key":"2020021223124193900_R11","doi-asserted-by":"crossref","unstructured":"Feder JN, Tsuchihashi Z, Irrinki A, et al. The hemochromatosis founder mutation in HLA-H disrupts \u03b22-microglobulin interaction and cell surface expression.J Biol Chem. 1997;272:14025\u201314028.","DOI":"10.1074\/jbc.272.22.14025"},{"key":"2020021223124193900_R12","doi-asserted-by":"crossref","unstructured":"Feder JN, Penny DM, Irrinki A, et al. The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding.Proc Natl Acad Sci U S A. 1998;95:1472\u20131477.","DOI":"10.1073\/pnas.95.4.1472"},{"key":"2020021223124193900_R13","doi-asserted-by":"crossref","unstructured":"Lebron JA, West AP Jr,. Bjorkman PJ. The hemochromatosis protein HFE competes with transferrin for binding to the transferrin receptor.J Mol Biol. 1999;294:239\u2013245.","DOI":"10.1006\/jmbi.1999.3252"},{"key":"2020021223124193900_R14","doi-asserted-by":"crossref","unstructured":"Roy CN, Penny DM, Feder JN, Enns C. The hereditary hemochromatosis protein, HFE, specifically regulates transferrin-mediated iron uptake in HeLa cells. J Biol Chem. 1999;274:9022\u20139028.","DOI":"10.1074\/jbc.274.13.9022"},{"key":"2020021223124193900_R15","doi-asserted-by":"crossref","unstructured":"Finch C. Regulators of iron balance in humans.Blood. 1994;84:1697\u20131702.","DOI":"10.1182\/blood.V84.6.1697.1697"},{"key":"2020021223124193900_R16","doi-asserted-by":"crossref","unstructured":"Andrews NC. Disorders of iron metabolism.N Engl J Med. 1999;341:1986\u20131995.","DOI":"10.1056\/NEJM199912233412607"},{"key":"2020021223124193900_R17","doi-asserted-by":"crossref","unstructured":"Schiffer LM, Brann I, Cronkite EP, Reisenstein P. Iron absorption and excretion in aregenerative anemia.Acta Haematol. 1966;35:80\u201391.","DOI":"10.1159\/000209113"},{"key":"2020021223124193900_R18","unstructured":"Modell B, Bordoukas V. The clinical approach to thalassemia. New York, NY: Grune and Stratton; 1984."},{"key":"2020021223124193900_R19","unstructured":"Valberg LS, Ghent CN, Lloyd DA, Frei JV, Chamberlain MJ. Iron absorption in idiopathic hemochromatosis: relationship to serum ferritin concentration in asymptomatic relatives.Clin Invest Med. 1979;2:17\u201322."},{"key":"2020021223124193900_R20","unstructured":"Williams R, Williams HS, Scheuer PJ, Pitcher CS, Loiseau E, Sherlock S. Iron absorption and siderosis in chronic liver disease.QJM. 1967;141:151\u2013167."},{"key":"2020021223124193900_R21","unstructured":"Sargent T, Saito H, Winchell HS. Iron absorption in hemochromatosis before and after phlebotomy therapy.J Nucl Med. 1971;12:660\u2013667."},{"key":"2020021223124193900_R22","doi-asserted-by":"crossref","unstructured":"Milder MS, Cook JD, Finch CA. Influence of food iron absorption on the plasma iron level in idiopathic hemochromatosis.Acta Haematol. 1978;60:65\u201375.","DOI":"10.1159\/000207699"},{"key":"2020021223124193900_R23","doi-asserted-by":"crossref","unstructured":"Edwards CQ, Griffen L.M, Kaplan J, Kushner JP. Twenty-four hour variation of transferrin saturation in treated and untreated hemochromatosis homozygotes.J Intern Med. 1989;226:373\u2013379.","DOI":"10.1111\/j.1365-2796.1989.tb01411.x"},{"key":"2020021223124193900_R24","doi-asserted-by":"crossref","unstructured":"Bulaj ZJ, Ajioka RS, Phillips JD et al. Disease-related conditions in relatives of patients with hemochromatosis.N Engl J Med. 2000;343:1529\u20131535.","DOI":"10.1056\/NEJM200011233432104"},{"key":"2020021223124193900_R25","unstructured":"Iron Overload and Hereditary Hemochromatosis. RFP No. NIH-NHLBI-HC99-19, July 12, 1999. http:\/\/www.nhlbi.gov\/funding\/inits\/archive\/rfp99-19.htm"},{"key":"2020021223124193900_R26","doi-asserted-by":"crossref","unstructured":"Olynyk JK, Cullen DJ, Aquilia S, et al. A population-based study of the clinical expression of the hemochromatosis gene.N Engl J Med. 1999;341:718\u2013724.","DOI":"10.1056\/NEJM199909023411002"},{"key":"2020021223124193900_R27","unstructured":"Title 21, Code of Federal Regulations, Part 640.3(d)."},{"key":"2020021223124193900_R28","doi-asserted-by":"crossref","unstructured":"Jeffrey G, Adams PC. Blood from patients with hereditary hemochromatosis\u2014a wasted resource? Transfusion. 1999;39:549\u2013550.","DOI":"10.1046\/j.1537-2995.1999.39060549.x"},{"key":"2020021223124193900_R29","doi-asserted-by":"crossref","unstructured":"McDonnell SM, Grindon AJ, Preston BL, et al. A survey of phlebotomy among persons with hemochromatosis.Transfusion. 1999;39:651\u2013656.","DOI":"10.1046\/j.1537-2995.1999.39060651.x"},{"key":"2020021223124193900_R30","doi-asserted-by":"crossref","unstructured":"Tan L, Khan MK, Hawk JC. Use of blood therapeutically drawn from hemochromatosis patients. Council on Scientific Affairs, American Medical Association.Transfusion. 1999;39:1018\u20131026.","DOI":"10.1046\/j.1537-2995.1999.39091018.x"},{"key":"2020021223124193900_R31","doi-asserted-by":"crossref","unstructured":"Domen RE. Paid-versus-volunteer blood donation in the United States: a historical review.Transfus Med Rev. 1995;9:53\u201359.","DOI":"10.1016\/S0887-7963(05)80030-6"},{"key":"2020021223124193900_R32","doi-asserted-by":"crossref","unstructured":"Strauss RG, Ludwig GA, Smith MV, et al. Concurrent comparison of the safety of paid cytapheresis and volunteer whole-blood donors.Transfusion. 1994;34:116\u2013121.","DOI":"10.1046\/j.1537-2995.1994.34294143937.x"},{"key":"2020021223124193900_R33","unstructured":"Nightingale SD. Summary of Advisory Committee Meeting of April 29 and 30, 1999, May 13, 1999. http:\/\/www.hhs.gov\/partner\/bloodsafety\/summary\/apr99sum.html"},{"key":"2020021223124193900_R34","unstructured":"Henney JE. Memorandum: Blood Donations by Individuals with Hemochromatosis, August 10, 1999. http:\/\/www.hhs.gov\/bloodsafety\/transcripts\/memo1.html"},{"key":"2020021223124193900_R35","doi-asserted-by":"crossref","unstructured":"Edwards CQ, Kushner JP. Screening for hemochromatosis.N Engl J Med. 1993;328:1616\u20131620.","DOI":"10.1056\/NEJM199306033282208"},{"key":"2020021223124193900_R36","unstructured":"Title 21. Code of Federal Regulations, Part 640.3(f)."},{"key":"2020021223124193900_R37","doi-asserted-by":"crossref","unstructured":"Barton JC, McDonnell SM, Adams PC, et al. Management of hemochromatosis. Hemochromatosis Management Working Group.Ann Intern Med. 1998;129:932\u2013939.","DOI":"10.7326\/0003-4819-129-11_Part_2-199812011-00003"},{"key":"2020021223124193900_R38","unstructured":"Guillemin C, Vigneron C, Streiff F. Serum and erythrocyte ferritin in regular blood donors.Nouv Rev Fr Hematol. 1992;34:259\u2013262."},{"key":"2020021223124193900_R39","doi-asserted-by":"crossref","unstructured":"Milman N, Sondergaard M. Iron stores in male blood donors evaluated by serum ferritin.Transfusion. 1984;24:464\u2013468.","DOI":"10.1046\/j.1537-2995.1984.24685066801.x"},{"key":"2020021223124193900_R40","doi-asserted-by":"crossref","unstructured":"Milman N, Sondergaard M, Sorensen CM. Iron stores in female blood donors evaluated by serum ferritin.Blut. 1985;51:337\u2013345.","DOI":"10.1007\/BF00320044"},{"key":"2020021223124193900_R41","doi-asserted-by":"crossref","unstructured":"Riedel HD, Remus AJ, Fitscher BA, Stremmel W. Characterization and partial purification of a ferrireductase from human duodenal microvillus membranes.Biochem J. 1995;309:745\u2013748.","DOI":"10.1042\/bj3090745"},{"key":"2020021223124193900_R42","doi-asserted-by":"crossref","unstructured":"McKie AT, Barrow D, Latunde-Dada GO, et al. An iron-regulated ferric reductase associated with the absorption of dietary iron.Science. 2001;291:1755\u20131759.","DOI":"10.1126\/science.1057206"},{"key":"2020021223124193900_R43","doi-asserted-by":"crossref","unstructured":"Gunshin H, Mackenzie, B., Berger, UV, et al. Cloning and characterization of a mammalian proton-coupled metal-ion transporter.Nature. 1997;388:482\u2013488.","DOI":"10.1038\/41343"},{"key":"2020021223124193900_R44","doi-asserted-by":"crossref","unstructured":"Fleming MD, Trenor, CC, Su MA, et al. Microcytic anaemia mice have a mutation in Nramp2, a candidate iron transporter gene.Nat Genet. 1997;16:383\u2013386.","DOI":"10.1038\/ng0897-383"},{"key":"2020021223124193900_R45","doi-asserted-by":"crossref","unstructured":"Donovan A, Brownlie A, Zhou Y, et al. Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter.Nature. 2000;403:776\u2013781.","DOI":"10.1038\/35001596"},{"key":"2020021223124193900_R46","doi-asserted-by":"crossref","unstructured":"McKie AT, Marciani, P., Rolfs, A, et al. A novel duodenal iron-regulated tranporter, IREG1, implicated in the basolateral transfer of iron to the circulation. Mol Cell. 2000;5:299\u2013309.","DOI":"10.1016\/S1097-2765(00)80425-6"},{"key":"2020021223124193900_R47","doi-asserted-by":"crossref","unstructured":"Abboud S, Haile DJ. A novel mammalian iron-regulated protein involved in intracellular iron metabolism.J Biol Chem. 2000;275:19906\u201319912.","DOI":"10.1074\/jbc.M000713200"},{"key":"2020021223124193900_R48","doi-asserted-by":"crossref","unstructured":"Vulpe CD, Kuo YM, Murphy TL, et al. Hephaestin, a ceruloplasmin homologue implicated in intestinal iron transport, is defective in the sla mouse.Nat Genet. 1999;21:195\u2013199.","DOI":"10.1038\/5979"},{"key":"2020021223124193900_R49","doi-asserted-by":"crossref","unstructured":"Njajou OT, Vaessen N, Joosse M, et al. A mutation in SLC11A3 is associated with autosomal dominant hemochromatosis.Nat Genet. 2001;28:213\u2013214.","DOI":"10.1038\/90038"},{"key":"2020021223124193900_R50","unstructured":"Bothwell TH, Charlton RW, Motulsky AG. Hemochromtosis. In Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Basis of Inherited Diseases, Vol. II. New York, NY: McGraw-Hill; 1995:2237-2269"},{"key":"2020021223124193900_R51","doi-asserted-by":"crossref","unstructured":"Cook JD, Hershko C, Finch CA. Storage iron kinetics V. Iron exchange in the rat.Br J Haematol. 1973;25:695\u2013706.","DOI":"10.1111\/j.1365-2141.1973.tb01782.x"},{"key":"2020021223124193900_R52","unstructured":"Hershko C. Storage iron regulation.Prog Hematol. 1977;10:105\u2013148."},{"key":"2020021223124193900_R53","unstructured":"Shelanski HA. Acute and chronic toxicity tests of carbonyl iron powder. Bull Nat Formulary Committee. 1950;18:87\u201394."},{"key":"2020021223124193900_R54","doi-asserted-by":"crossref","unstructured":"Finch CA, Cook JD, Labbe RF, Culala M. Effect of blood donation on iron stores as evaluated by serum ferritin. Blood. 1977;50:441\u2013447.","DOI":"10.1182\/blood.V50.3.441.441"},{"key":"2020021223124193900_R55","unstructured":"Sacks PV, Houchin DN. Comparative bioavailability of elemental iron powders for repair of iron deficiency anemia in rats. Studies of efficacy and toxicity of carbonyl iron. Am J Clin Nutr. 1978;31:566\u2013571."},{"key":"2020021223124193900_R56","doi-asserted-by":"crossref","unstructured":"Crosby WH. Prescribing iron? Think safety. Arch Intern Med. 1978;138:766\u2013767.","DOI":"10.1001\/archinte.1978.03630290062020"},{"key":"2020021223124193900_R57","doi-asserted-by":"crossref","unstructured":"Simon TL, Garry PJ, Hooper EM. Iron stores in blood donors. JAMA. 1981;245:2038\u20132043.","DOI":"10.1001\/jama.1981.03310450030018"},{"key":"2020021223124193900_R58","doi-asserted-by":"crossref","unstructured":"Skikne B, Lynch S, Borek D, Cook J. Iron and blood donation. Clin Haematol. 1984;13:271\u2013287.","DOI":"10.1016\/S0308-2261(18)30044-4"},{"key":"2020021223124193900_R59","doi-asserted-by":"crossref","unstructured":"Gordeuk VR, Brittenham GM, McLaren CE, Hughes MA, Keating LJ. Carbonyl iron therapy for iron deficiency anemia. Blood. 1986;67:745\u2013752.","DOI":"10.1182\/blood.V67.3.745.745"},{"key":"2020021223124193900_R60","unstructured":"Huebers HA, Brittenham GM, Csiba E, Finch CA. Absorption of carbonyl iron. J Lab Clin Med. 1986;108:473\u2013478."},{"key":"2020021223124193900_R61","doi-asserted-by":"crossref","unstructured":"Gordeuk VR, Brittenham GM, Hughes MA, Keating LJ. Carbonyl iron for short-term supplementation in female blood donors. Transfusion. 1987;27:80\u201385.","DOI":"10.1046\/j.1537-2995.1987.27187121482.x"},{"key":"2020021223124193900_R62","doi-asserted-by":"crossref","unstructured":"Gordeuk VR, Brittenham GM, Hughes M, Keating LJ, Opplt JJ. High-dose carbonyl iron for iron deficiency anemia: a randomized double-blind trial. Am J Clin Nutr. 1987;46:1029\u20131034.","DOI":"10.1093\/ajcn\/46.6.1029"},{"key":"2020021223124193900_R63","doi-asserted-by":"crossref","unstructured":"Gordeuk VR, Brittenham GM, Bravo J, Hughes MA, Keating LJ. Prevention of iron deficiency with carbonyl iron in female blood donors. Transfusion. 1990;30:239\u2013245.","DOI":"10.1046\/j.1537-2995.1990.30390194345.x"},{"key":"2020021223124193900_R64","doi-asserted-by":"crossref","unstructured":"Devasthali SD, Gordeuk VR, Brittenham GM, Bravo JR, Hughes MA, Keating LJ. Bioavailability of carbonyl iron: a randomized, double-blind study. Eur J Haematol. 1991;46:272\u2013278.","DOI":"10.1111\/j.1600-0609.1991.tb01538.x"},{"key":"2020021223124193900_R65","doi-asserted-by":"crossref","unstructured":"Mills KC, Curry SC. Acute iron poisoning. Emerg Med Clin N Amer. 1994;12:397\u2013413.","DOI":"10.1016\/S0733-8627(20)30435-1"},{"key":"2020021223124193900_R66","doi-asserted-by":"crossref","unstructured":"Anderson AC. Iron poisoning in children. Curr Opin Pediatr. 1994;6:289\u2013294.","DOI":"10.1097\/00008480-199406000-00010"},{"key":"2020021223124193900_R67","unstructured":"Brittenham GM, Gordeuk VR, Bravo JR, et al. Carbonyl iron supplementation for female blood donors. Blood1996;88(Suppl. 1):360a."},{"key":"2020021223124193900_R68","doi-asserted-by":"crossref","unstructured":"Punnonen K, Rajamaki A. Evaluation of iron status of Finnish blood donors using serum transferrin receptor. Transfus Med. 1999;9:131\u2013134.","DOI":"10.1046\/j.1365-3148.1999.00191.x"},{"key":"2020021223124193900_R69","doi-asserted-by":"crossref","unstructured":"Alvarez-Ossorio L, Kirchner H, Kluter H, Schlenke P. Low ferritin levels indicate the need for iron supplementation: strategy to minimize iron-depletion in regular blood donors. Transfus Med. 2000;10:107\u2013112.","DOI":"10.1046\/j.1365-3148.2000.00239.x"},{"key":"2020021223124193900_R70","doi-asserted-by":"crossref","unstructured":"Morris CC. Pediatric iron poisonings in the United States. South Med J. 2000;93:352\u2013358.","DOI":"10.1097\/00007611-200093040-00001"},{"key":"2020021223124193900_R71","doi-asserted-by":"crossref","unstructured":"Alexander HD, Sherlock JP, Bharucha C. Red cell indices as predictors of iron depletion in blood donors. Clin Lab Haematol. 2000;22:253\u2013258.","DOI":"10.1046\/j.1365-2257.2000.00323.x"},{"key":"2020021223124193900_R72","unstructured":"Brittenham GM. Disorders of iron metabolism: iron deficiency and overload. In Hoffman R, Shattil SJ, Furie B, Cohen HJ, Silberstein LE, McGave P, eds. Hematology: Basic Principles and Practice. New York: Churchill Livingstone; 2000:397-428."},{"key":"2020021223124193900_R73","doi-asserted-by":"crossref","unstructured":"Wu Y, Glynn SA, Schreiber GB, et al. First-time blood donors: demographic trends. Transfusion. 2001;41:360\u2013364.","DOI":"10.1046\/j.1537-2995.2001.41030360.x"},{"key":"2020021223124193900_R74","doi-asserted-by":"crossref","unstructured":"Heath AL, Skeaff CM, Williams S, Gibson RS. The role of blood loss and diet in the aetiology of mild iron deficiency in premenopausal adult New Zealand women. Public Health Nutr. 2001;4:197\u2013206.","DOI":"10.1079\/PHN200054"}],"container-title":["Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/hematology\/article-pdf\/2001\/1\/422\/1713202\/422.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/hematology\/article-pdf\/2001\/1\/422\/1713202\/422.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,10]],"date-time":"2021-06-10T11:38:56Z","timestamp":1623325136000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/hematology\/article\/2001\/1\/422\/18640\/Preserving-the-National-Blood-Supply"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,1,1]]},"references-count":74,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2001,1,1]]}},"URL":"https:\/\/doi.org\/10.1182\/asheducation-2001.1.422","relation":{},"ISSN":["1520-4391","1520-4383"],"issn-type":[{"value":"1520-4391","type":"print"},{"value":"1520-4383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,1,1]]}}}